Global Pharmaceutical Excipients Market

Pharmaceutical Excipients Market Size, Share, Growth Analysis, By Product(Organic Chemicals, and Inorganic Chemicals.), By Functionality(Fillers and Diluents, Suspending and Viscosity Agents), By Formulations(Topical Formulations, Oral Formulations), By End User(Pharmaceuticals Companies, Research Organization) - Industry Forecast 2024-2031


Report ID: SQMIG35I2120 | Region: Global | Published Date: February, 2024
Pages: 242 | Tables: 126 | Figures: 77

Pharmaceutical Excipients Market Insights

Pharmaceutical Excipients Market size was valued at USD 8.6 billion in 2019 and is poised to grow from USD 9.11 billion in 2023 to USD 14.41 billion by 2031, growing at a CAGR of 5.9% in the forecast period (2024-2031).

The rising prevalence of chronic and lifestyle diseases in the world, as well as significant investments made by the pharmaceutical industry in the development of biologics, are expected to have a significant impact on the growth of the global market over the forecasted period. But during the projection period, market expansion is expected to be slightly constrained by the expensive and time-consuming process of developing new medications. Furthermore, the widespread adoption of pharmaceutical production in numerous emerging countries is expected to provide promising opportunities for the company to expand over time.

Excipients can occur in a variety of forms and sizes, such as sweets that intensify the drug's unpleasant flavor. Excipients also have an impact on the medicine's flavor, stability, and efficacy. Moreover, binders and disintegrants make sure the chemical is easy to ingest and functions as intended. The demand for excipients in the global pharmaceutical excipients market is anticipated to increase as a result of the aforementioned characteristics. The cost and time-intensive nature of the drug development process as well as the tightening regulatory standards for the approval of pharmaceuticals and excipients are expected to hinder the market growth, nevertheless.

US Pharmaceutical Excipients Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Pharmaceutical Excipients Market size was valued at USD 8.6 billion in 2019 and is poised to grow from USD 9.11 billion in 2023 to USD 14.41 billion by 2031, growing at a CAGR of 5.9% in the forecast period (2024-2031).

The main business tactics used by the majority of companies in the pharmaceutical excipients market are business expansions, new product launches, mergers and acquisitions, and partnerships with academic institutions. Over the projection period, the market will experience advancements due to the pharmaceutical industry's requirement for novel functional excipients. Due to this strategy, market leaders are constantly launching a variety of new excipients and modified categories of excipients already on the market. 'Ashland Holdings Inc.', 'BASF SE', 'Dow Inc.', 'Evonik Industries AG', 'Roquette Frères S.A.', 'Kerry Group plc', 'Lubrizol Corporation', 'Croda International Plc', 'Innophos Holdings, Inc.', 'Dupont de Nemours, Inc.', 'Colorcon Inc.', 'Wacker Chemie AG', 'Shin-Etsu Chemical Co., Ltd.', 'Archer Daniels Midland Company', 'Pfanstiehl, Inc.', 'JRS Pharma GmbH & Co. KG', 'IMCD Group B.V.', 'Signet Chemical Corporation Pvt. Ltd.', 'FMC Corporation', 'Meggle Group Wasserburg'

Due to their similarity to biomolecules naturally found in the body, high potency, and minimal side effects, biopharmaceuticals are steadily gaining popularity in the pharmaceutical sector. Hence, one of the pharmaceutical industry's fastest growing segments is the biopharmaceuticals form. Additionally, new ideas, including regenerative medicines, are being continuously improved. This offers a significant chance for the market to expand as a result. The majority of the drugs that are now sold in the market are among the top 15 biopharmaceutical items. As a result, the vast majority of pharma firms globally are gradually shifting their R&D focus to macromolecule products.

Due to rising demand for pharmaceutical and biopharmaceutical medications as well as new product launches, the market is predicted to have considerable expansion throughout the forecast period. In order to help active pharmaceutical components, work better and provide themselves a competitive edge, binders have gradually come to be recognized by the pharmaceutical industry. Also, as pharmaceutical output increases, the demand for binders is anticipated to rise as well, which is anticipated to fuel the segment's expansion. For instance, India's pharmaceutical manufacturing was third in the world by volume and ranked 14th by value in 2022, according to the India Brand Equity Foundation's 2022 study. They are naturally produced, multifunctional excipients that adhere to both pharmaceutical and food monographs and can be used as binders, fillers, and other uses for oral solid dosage forms. The market segment is thus expected to witness significant growth during in the forecast period as a consequence of the factors mentioned.

North America currently holds the largest market share for pharmaceutical excipients and is expected to continue on a similar path during the forecast period. The market will experience significant expansion throughout the projected period due to factors including the rapidly expanding pharmaceutical sector, rising demand for functional excipients, the presence of major players in the area, and technological advancements. It is expected that rising R&D investment will drive market growth. The introduction of technologically improved or superior excipients also accelerates the market's growth. For instance, Apisolex was introduced in the United States in May 2022 by Lubrizol Life Science (LLS) Health, one of the world leaders in speeding success and innovation in pharmaceutical research. It is a brand-new excipient for parenteral medicinal formulations that improves solubility. Hence, it is projected that the aforementioned reasons will support the market's expansion in the North American region.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Pharmaceutical Excipients Market

Product ID: SQMIG35I2120

$5,300
BUY NOW GET FREE SAMPLE